인플루엔자 백신 시장 보고서(2026년)

Influenza vaccines are flu vaccines developed to provide immunity against influenza viruses. These vaccines are often quadrivalent formulations designed to protect against four different influenza strains, including two influenza A viruses and two influenza B viruses.

The main types of influenza vaccines include inactivated vaccines and live attenuated vaccines. Inactivated vaccines contain killed or inactivated viruses that stimulate an immune response without causing disease and are used to prevent infection and lessen the severity of illness caused by influenza viruses. These vaccines are available in quadrivalent and trivalent formulations and are administered through injections and nasal sprays for both pediatric and adult populations. They are distributed through hospitals and pharmacies, government and institutional supply channels, and other distribution networks.

Tariffs have affected the influenza vaccines market by increasing import costs for raw materials, vials, syringes, and specialized manufacturing equipment. This has led to higher production costs, particularly impacting quadrivalent vaccine segments and regions like Asia-Pacific and Europe where significant vaccine manufacturing hubs exist. While tariffs create cost pressures and supply chain disruptions, they have also incentivized manufacturers to localize production and invest in domestic vaccine facilities, potentially boosting regional vaccine security and self-sufficiency.

The influenza vaccines market research report is one of a series of new reports from The Business Research Company that provides influenza vaccines market statistics, including influenza vaccines industry global market size, regional shares, competitors with a influenza vaccines market share, detailed influenza vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the influenza vaccines industry. This influenza vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The influenza vaccines market size has grown strongly in recent years. It will grow from $9.04 billion in 2025 to $9.71 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of seasonal influenza, limited public awareness in early 2000s, predominance of trivalent vaccines, low global manufacturing capacity, reliance on traditional egg-based production methods.

The influenza vaccines market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing adoption of quadrivalent vaccines, expansion of precision medicine approaches, growing government vaccination initiatives, development of cell-based and recombinant vaccines, enhanced cold chain and distribution infrastructure. Major trends in the forecast period include seasonal vaccine formulation optimization, expansion of pediatric immunization programs, increase in government-funded flu vaccination campaigns, adoption of novel adjuvants for enhanced immunogenicity, growth in home-based and outpatient vaccine delivery.

The increasing incidence of seasonal influenza is anticipated to drive the growth of the influenza vaccine market in the coming years. Seasonal influenza is a contagious respiratory illness caused by influenza viruses that circulate predominantly during certain periods of the year, most often in colder seasons. The rising burden of seasonal influenza is associated with factors such as antigenic drift, heightened population susceptibility, environmental influences, incomplete vaccine coverage, and the absence of universal immunization. Influenza vaccines play a critical role in lowering the incidence of seasonal influenza by providing protection against the virus strains expected to circulate each season. For example, in November 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, the 2022-2023 flu season in the United States resulted in approximately 31 million influenza-related illnesses, 14 million medical visits, 360,000 hospitalizations, and 21,000 deaths. As a result, the growing incidence of seasonal influenza is contributing to the expansion of the influenza vaccine market.

Major companies operating in the influenza vaccine market are focusing on advanced product innovations, such as quadrivalent seasonal influenza vaccines, to strengthen their respiratory vaccine portfolios and overall financial performance. Quadrivalent seasonal influenza vaccines are formulated to protect against four influenza virus strains, including two influenza A strains and two influenza B strains. For instance, in September 2023, Clover Biopharmaceuticals Ltd., a China-based biotechnology company, launched AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine. This product is the only imported quadrivalent seasonal influenza vaccine approved in China for individuals aged three years and older. Its quadrivalent formulation enhances vaccine effectiveness by offering broader protection, particularly against varying influenza B strains, compared with trivalent vaccines.

In February 2023, Clover Biopharmaceuticals Ltd. partnered with Adimmune Corporation to exclusively commercialize AdimFlu-S (QIS) in mainland China. Through this partnership, Clover aims to expand its respiratory vaccine franchise by leveraging its established commercial infrastructure to distribute a high-quality quadrivalent influenza vaccine and meet the rising demand for influenza prevention in the Chinese market. Adimmune Corporation is a Taiwan-based vaccine manufacturer engaged in the development and production of essential vaccines.

Major companies operating in the influenza vaccines market are Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd

North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the influenza vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The influenza vaccines market consists of sales of recombinant influenza vaccines, high-dose influenza vaccines, cell-based influenza vaccines, and egg-based influenza vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Influenza Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses influenza vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for influenza vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The influenza vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Inactivated; Live Attenuated
• 2) By Valency: Quadrivalent; Trivalent
• 3) By Route Of Administration: Injection; Nasal Spray
• 4) By Age Group: Pediatric; Adult
• 5) By Distribution Channel: Hospitals And Pharmacies; Government And Institutional Supply; Other Distribution Channels
• Subsegments:
• 1) By Inactivated: Trivalent Inactivated Vaccines (TIV); Quadrivalent Inactivated Vaccines (QIV)
• 2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV); Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)
• Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Sanofi-Aventis LLC; GlaxoSmithKline plc; Serum Institute of India Private Limited; Seqirus Inc.; CSL Limited; Daiichi Sankyo Company Limited; Moderna Inc.; Novavax AB; Bharat Biotech International Limited; Valneva SE; Shionogi & Co Ltd.; Sinovac Biotech Co Ltd.; Walvax Biotechnology Co Ltd.; Hualan Biological Engineering Inc.; China National Pharmaceutical Group Corporation; Green Cross Corporation; Mitsubishi Tanabe Pharma Corporation; Osivax; Vaxess Technologies Inc.; Gamma Vaccines Pty Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Influenza Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Influenza Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Influenza Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Influenza Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Seasonal Vaccine Formulation Optimization
  • 4.2.2 Expansion Of Pediatric Immunization Programs
  • 4.2.3 Increase In Government-Funded Flu Vaccination Campaigns
  • 4.2.4 Adoption Of Novel Adjuvants For Enhanced Immunogenicity
  • 4.2.5 Growth In Home-Based And Outpatient Vaccine Delivery

5. Influenza Vaccines Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Government & Public Health Programs
• 5.4 Pharmacies
• 5.5 Pediatric Care Centers

6. Influenza Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Influenza Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Influenza Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Influenza Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Influenza Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Influenza Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Influenza Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Influenza Vaccines Market Segmentation

• 9.1. Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inactivated, Live Attenuated
• 9.2. Global Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Quadrivalent, Trivalent
• 9.3. Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injection, Nasal Spray
• 9.4. Global Influenza Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pediatric, Adult
• 9.5. Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels
• 9.6. Global Influenza Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
• 9.7. Global Influenza Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

10. Influenza Vaccines Market Regional And Country Analysis

• 10.1. Global Influenza Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Influenza Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Influenza Vaccines Market

• 11.1. Asia-Pacific Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Influenza Vaccines Market

• 12.1. China Influenza Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Influenza Vaccines Market

• 13.1. India Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Influenza Vaccines Market

• 14.1. Japan Influenza Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Influenza Vaccines Market

• 15.1. Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Influenza Vaccines Market

• 16.1. Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Influenza Vaccines Market

• 17.1. South Korea Influenza Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Influenza Vaccines Market

• 18.1. Taiwan Influenza Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Influenza Vaccines Market

• 19.1. South East Asia Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Influenza Vaccines Market

• 20.1. Western Europe Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Influenza Vaccines Market

• 21.1. UK Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Influenza Vaccines Market

• 22.1. Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Influenza Vaccines Market

• 23.1. France Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Influenza Vaccines Market

• 24.1. Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Influenza Vaccines Market

• 25.1. Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Influenza Vaccines Market

• 26.1. Eastern Europe Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Influenza Vaccines Market

• 27.1. Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Influenza Vaccines Market

• 28.1. North America Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Influenza Vaccines Market

• 29.1. USA Influenza Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Influenza Vaccines Market

• 30.1. Canada Influenza Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Influenza Vaccines Market

• 31.1. South America Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Influenza Vaccines Market

• 32.1. Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Influenza Vaccines Market

• 33.1. Middle East Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Influenza Vaccines Market

• 34.1. Africa Influenza Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Influenza Vaccines Market Regulatory and Investment Landscape

36. Influenza Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Influenza Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Influenza Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Influenza Vaccines Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis

37. Influenza Vaccines Market Other Major And Innovative Companies

• Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax

38. Global Influenza Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Influenza Vaccines Market

40. Influenza Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Influenza Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Influenza Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Influenza Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer